67 related articles for article (PubMed ID: 26416044)
1. Hepatic steatosis is associated with higher incidence of liver metastasis in patients with metastatic breast cancer; an observational clinical study.
Ocak Duran A; Yildirim A; Inanc M; Karaca H; Berk V; Bozkurt O; Ozaslan E; Ucar M; Ozkan M
J BUON; 2015; 20(4):963-9. PubMed ID: 26416044
[TBL] [Abstract][Full Text] [Related]
2. Fatty liver decreases the risk of liver metastasis in patients with breast cancer: a two-center cohort study.
Wu W; Chen J; Ye W; Li X; Zhang J
Breast Cancer Res Treat; 2017 Nov; 166(1):289-297. PubMed ID: 28741275
[TBL] [Abstract][Full Text] [Related]
3. Hepatic steatosis is associated with lower incidence of liver metastasis from colorectal cancer.
Murono K; Kitayama J; Tsuno NH; Nozawa H; Kawai K; Sunami E; Akahane M; Watanabe T
Int J Colorectal Dis; 2013 Aug; 28(8):1065-72. PubMed ID: 23392476
[TBL] [Abstract][Full Text] [Related]
4. Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases.
Pathak S; Tang JM; Terlizzo M; Poston GJ; Malik HZ
Eur J Surg Oncol; 2010 Jan; 36(1):52-7. PubMed ID: 19879103
[TBL] [Abstract][Full Text] [Related]
5. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
6. About the article "Hepatic steatosis is associated with higher incidence of liver metastasis in patients with metastatic breast cancer; an observational clinical study" by Duran et al.
Kocoglu H; Tural D
J BUON; 2016; 21(1):284. PubMed ID: 27061564
[No Abstract] [Full Text] [Related]
7. Quantification of hepatic steatosis: a comparison of computed tomography and magnetic resonance indices in candidates for living liver donation.
Maruzzelli L; Parr AJ; Miraglia R; Tuzzolino F; Luca A
Acad Radiol; 2014 Apr; 21(4):507-13. PubMed ID: 24594420
[TBL] [Abstract][Full Text] [Related]
8. Hepatic capsular retraction in metastatic carcinoma of the breast occurring with increase or decrease in size of subjacent metastasis.
Fennessy FM; Mortele KJ; Kluckert T; Gogate A; Ondategui-Parra S; Ros P; Silverman SG
AJR Am J Roentgenol; 2004 Mar; 182(3):651-5. PubMed ID: 14975965
[TBL] [Abstract][Full Text] [Related]
9. Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection.
Nishio T; Hatano E; Sakurai T; Taura K; Okuno M; Kasai Y; Seo S; Yasuchika K; Mori A; Kaido T; Uemoto S
Ann Surg Oncol; 2015 Jul; 22(7):2226-34. PubMed ID: 25395147
[TBL] [Abstract][Full Text] [Related]
10. Recurrence pattern in the presence of hepatosteatosis in breast cancer: does it facilitate liver metastasis?
Kus T; Cinkir HY; Aktas G; Abali H
Future Oncol; 2020 Jun; 16(18):1257-1267. PubMed ID: 32356676
[No Abstract] [Full Text] [Related]
11. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of long-term (5-year) survival in patients with metastatic breast cancer to the liver].
Kan N
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1780-4. PubMed ID: 17212106
[TBL] [Abstract][Full Text] [Related]
13. Baseline liver steatosis has no impact on liver metastases and overall survival in rectal cancer patients.
Besutti G; Damato A; Venturelli F; Bonelli C; Vicentini M; Monelli F; Mancuso P; Ligabue G; Pattacini P; Pinto C; Giorgi Rossi P
BMC Cancer; 2021 Mar; 21(1):253. PubMed ID: 33750342
[TBL] [Abstract][Full Text] [Related]
14. Frequency of hepatic contour abnormalities and signs of portal hypertension at CT in patients receiving chemotherapy for breast cancer metastatic to the liver.
Qayyum A; Lee GK; Yeh BM; Allen JN; Venook AP; Coakley FV
Clin Imaging; 2007; 31(1):6-10. PubMed ID: 17189839
[TBL] [Abstract][Full Text] [Related]
15. Multiple hepatic adenomas associated with liver steatosis at CT and MRI: a case-control study.
Furlan A; van der Windt DJ; Nalesnik MA; Sholosh B; Ngan KK; Pealer KM; Ijzermans JN; Federle MP
AJR Am J Roentgenol; 2008 Nov; 191(5):1430-5. PubMed ID: 18941081
[TBL] [Abstract][Full Text] [Related]
16. Frequency of Hepatic Metastatic Disease in Patients with Stage IV Breast Cancer Is Similar for Steatotic and Non-Steatotic Livers.
Haq A; Fraum TJ; Tao Y; Dehdashti F; LeBlanc M; Hoegger MJ; Luo J; Weilbaecher K; Peterson LL
Breast Cancer (Auckl); 2023; 17():11782234231166476. PubMed ID: 37181949
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases.
Vlastos G; Smith DL; Singletary SE; Mirza NQ; Tuttle TM; Popat RJ; Curley SA; Ellis LM; Roh MS; Vauthey JN
Ann Surg Oncol; 2004 Sep; 11(9):869-74. PubMed ID: 15342348
[TBL] [Abstract][Full Text] [Related]
18. Surgical and nonsurgical management of primary and metastatic liver tumors.
Zibari GB; Riche A; Zizzi HC; McMillan RW; Aultman DF; Boykin KN; Gonzalez E; Nandy I; Dies DF; Gholson CF; Holcombe RF; McDonald JC
Am Surg; 1998 Mar; 64(3):211-20; discussion 220-1. PubMed ID: 9520809
[TBL] [Abstract][Full Text] [Related]
19. Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases.
Hamady ZZ; Rees M; Welsh FK; Toogood GJ; Prasad KR; John TK; Lodge JP
Br J Surg; 2013 May; 100(6):820-6. PubMed ID: 23354994
[TBL] [Abstract][Full Text] [Related]
20. Curative liver resection for metastatic breast cancer.
Maksan SM; Lehnert T; Bastert G; Herfarth C
Eur J Surg Oncol; 2000 Apr; 26(3):209-12. PubMed ID: 10753531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
